• Journal of Haehwa Medicine
• /
• v.19 no.2
• /
• pp.173-177
• /
• 2011

We treated a 45 year-old male patient. He had Hypertension, Diabetes, Hyperlipidemia and Obesity. The main symptoms were Low-back pain, General body weakness, Abdominal discomfort. We diagnosed him as metabolic syndrome and prescribe Yagwanchunghyul-tang three times a day. We observed clinical symptoms Blood pressure, Capillary blood glucose, BMI, Body weight. Cholesterol, Triglyceride. After the treatment, The main symptom, blood pressure, capillary blood glucose(PP2hr), Hypercholesterol, Hypertriglyceride were improved. and BMI levels fell. This case shows that Yagwanchunghyul-tang has an effect on Metabolic syndrome like a Hypertension, Diabetes, Hyperlipidermia, Hypertriglyceride.

• Korean Journal of Health Education and Promotion
• /
• v.33 no.5
• /
• pp.59-70
• /
• 2016

Objectives: This study aimed to investigate the association between smoking cessation and metabolic syndrome components in Korean male and to clarify how long metabolic syndrome and its components remains after smoking cessation. Methods: A total of 4,408 participants from the Korean National Health and Nutrition Examination Surveys were included in this cross-sectional study. Smoking status was categorized into three groups, current-smoker, ex-smoker and non-smoker. Also smoking cessation period was categorized into three groups, less than 5 years, 5 years to 15 years and more than 15 years. Results: Smoking cessation were associated with prevalence of metabolic syndrome and its components. The multi-variate adjusted odds ratio for the prevalence of metabolic syndrome was 1.68(1.22-2.31) for smoker, 1.04(0.74-1.46) for ex-smoker, as compare with non-smoker; adjusted odds ratio for the prevalence of hypertriglyceride 2.17(1.77-2.66) for smoker, 1.27(1.02-1.59) for ex-smoker and high waist circumference 1.36(0.98-1.88) for smoker, 1.07(0.78-1.48) for ex-smoker, as compare with non-smoker. Conclusions: Smoking cessation in Korean male reduced odds ratio for the prevalence of metabolic syndrome and its 4 components except for hypertension.

• Korean Journal of Food Science and Technology
• /
• v.51 no.6
• /
• pp.558-564
• /
• 2019

Hypertriglyceridemia is one of the metabolic syndrome that is often observed as a result of lipid abnormalities. It is associated with other lipids, metabolic disorders, cardiovascular disease and liver disease. Korean red ginseng is known to affect obesity, dyslipidemia, liver disease and liver function, but the mechanism of its effect is not clear. This study examined the beneficial effects of hypertriglyceridemia and the mechanism of action of Jinan red ginseng extract (JRG) in hepatoma cells. To measure the levels of triglyceride accumulation, we studied the expression of proteins and mRNAs related to lipidogenesis in hepatoma cells (Huh7 and HepG2). JRG decreases the lipidogenic markers, peroxisome proliferator-activated receptor γ (PPARγ), CCAAT-enhancer-binding proteins α (C/EBPα) and C/EBPβ which are major regulators of triglyceride synthesis in hepatoma cells. We also found that JRG reduced sterol regulatory element binding proteins 1c (SREBP-1c), C/EBPα and C/EBPβ by regulating liver X receptor (LXR) and stearoyl CoA desaturase (SCD) expressions. In addition, the first-limited step of synthesis triglyceride (TG), glycerol-3-phosphate (G3P) is decreased by JRG. These results suggest that the anti-hypertriglyceride effect of JRG in hepatoma cells could be accompanied with the inhibition of lipidogenic transcription factors by regulating LXR and SCD expression.

• Journal of Community Nutrition
• /
• v.6 no.3
• /
• pp.131-136
• /
• 2004

The purpose of this study is to compare the relative risk of metabolic syndrome (MS) in middle aged adults with different body weights. 155 subjects living in urban Beijing were recruited from 24 neighborhood committees of urban Beijing. They were divided into normal weight, overweight and obese groups according to their BMIs. The general information of the subjects was collected using an interview-administered questionnaire. Standard procedure was followed to measure subject's weight, height and waist. Biochemical parameters (total cholesterol (TC), low- and high­density lipoprotein cholesterol (LDL-C ; HDL-C), triglyceride (TG), and fasting glucose) and blood pressure were also determined. The results indicated that the systolic and diastolic blood pressure, HDL-C of obese group was lower than that of the normal weight group. Fasting glucose of obese males was significantly higher than that of normal weight males. No significant difference of fasting glucose was found among female groups. No significant difference of TG was found among male groups, while TG of overweight and obese females was both significantly higher than normal weight females. There was no significant difference of TC and LDL-C among normal weight, overweight and obese groups in both males and females. The MS rate of obese males was significantly higher than the normal weight and overweight males, as was the female. The relative risk of MS in obese group was about 11 times higher (OR=11.249, $95\%CI$ = 3.812 - 33.191) than the normal weight group after adjusting for age, gender, smoking, drinking, family economic level and education status. It is concluded that obesity contributed to lower HDL-C, hypertriglyceride, hypertension and MS after controlling the effects of age, gender, socioeconomic status, alcohol drinking and smoking. Obese individuals have a higher risk of having MS than their normal weight counterparts.